Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Puma Biotechnology Inc. (NASDAQ: PBYI).

Full DD Report for PBYI

You must become a subscriber to view this report.


Recent News from (NASDAQ: PBYI)

Puma Biotechnology: Increasing Our Exposure
Thesis We sold our position in Tesaro ( TSRO ) and are increasing our exposure to Puma Biotechnology ( PBYI ) as we think that Puma can be a good acquisition target as a small-cap, $250 million sales, oncology company with promising growth prospects. Puma is expected to become cash flow ...
Source: SeekingAlpha
Date: December, 10 2018 06:43
Cancer Research Highlight: Puma Biotech's Basket Pays Off
Please note that I am affiliated with Avisol Capital Partners and their Total Pharma Tracker service. They have also covered the companies in this article in their writings, and I wanted to make readers aware of the potential for overlapping coverage. If you're interested in this serv...
Source: SeekingAlpha
Date: December, 08 2018 08:00
Puma Biotechnology to Present at Credit Suisse Healthcare Conference
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:10 a.m. MST (8:10 a.m. PST, 11:10 a.m. EST) on Wednesday, November 14, at the ...
Source: Business Wire
Date: November, 07 2018 16:15
Biotech Stocks and the Midterm Elections
HENDERSON, NV / ACCESSWIRE / November 7, 2018 / Midterm elections are expected to result in a split Congress, which should increase predictability for the biotech industry, and prevent, what some see as disruptive, government dictated pricing, less likely than if there is a Congress controll...
Source: ACCESSWIRE IA
Date: November, 07 2018 10:30
Microcaps mostly among midday movers
More news on: Datawatch Corporation, JinkoSolar Holding Co., Ltd., Yulong Eco-Materials, , Stocks on the move, Read more ...
Source: SeekingAlpha
Date: November, 05 2018 12:46
Puma Biotechnology: Dismal Growth, Some Silver Linings
In August, I concluded that a small speculative position might be warranted in shares of Puma Biotechnology ( PBYI ) . I was attracted to the fall in the shares, in combination with the fact that the company had an approved product, and the pick-up in sales for that drug seemed to be goin...
Source: SeekingAlpha
Date: November, 02 2018 16:00
Healthcare and Tech top list of midday movers (11/02/2018)
More news on: Pacific Biosciences of California, Emerge Energy Services LP, VivoPower International PLC, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: November, 02 2018 12:47
Apple losing big in premarket trade
Puma Biotechnology (NYSE: PBYI )  -39%  on Q3 earnings . More news on: Puma Biotechnology, Inc., Universal Display Corporation, Weight Watchers International, Inc., Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 02 2018 09:18
Sell-siders bearish on Puma Biotech after Q3 disappointment
Sell-side analysts weigh in Puma Biotechnology (NYSE: PBYI ) after it posted Q3 results yesterday that featured less-than-expected sequential growth for top seller Nerlynx (neratinib). More news on: Puma Biotechnology, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: November, 02 2018 08:59
JPMorgan and Barclays bearish on Puma in premarket healthcare analyst action
Abiomed (NASDAQ: ABMD ) upgraded to Buy with a $450 (19% upside) price target at BTIG Research after yesterday's fiscal Q2 beat. Shares up a fraction premarket. More news on: ABIOMED, Inc., Emergent BioSolutions Inc., Adverum Biotechnologies, Inc., Healthcare stocks news, Stocks on the mov...
Source: SeekingAlpha
Date: November, 02 2018 07:59

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1449.9048.3550.7547.651,401,407
2018-01-1093.4096.0596.7592.90533,331
2018-01-0992.9593.8095.1592.30515,468
2018-01-0894.5092.5595.038589.60540,700
2018-01-0596.5595.3597.5594.85381,652

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1463,321212,85829.7480Cover
2018-12-1341,452113,94636.3786Short
2018-12-1240,498137,73229.4035Cover
2018-12-1161,461168,86636.3963Short
2018-12-1077,143200,84238.4098Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PBYI.


About Puma Biotechnology Inc. (NASDAQ: PBYI)

Logo for Puma Biotechnology Inc. (NASDAQ: PBYI)

Not available

 

 

 

Current Management

  • Alan H. Auerbach / CEO, President, Founder
  • Richard Bryce / Senior VP, Research amp Development
  • Charles R. Eyler / Senior VP, Treasurer
  • Richard Phillips / Senior VP
  • Thomas R. Malley /
  • Jay M. Moyes /

Current Share Structure

  • Market Cap: $2,043,717,575 - 05/18/2018
  • Authorized: 100,000,000 - 12/31/2011
  • Issue and Outstanding: 37,811,611 - 05/07/2018

 


Recent Filings from (NASDAQ: PBYI)

Filing Type: CT ORDERFiling Source: edgar
Filing Date: August, 28 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 09 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 09 2018
Amendment to a previously filed Form 4
Filing Type: 4/AFiling Source: edgar
Filing Date: August, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 26 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: June, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 04 2018

 

 


Daily Technical Chart for (NASDAQ: PBYI)

Daily Technical Chart for (NASDAQ: PBYI)


Stay tuned for daily updates and more on (NASDAQ: PBYI)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: PBYI)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PBYI is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PBYI and does not buy, sell, or trade any shares of PBYI. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/